Sleep Aids Market Size, Share, Growth Analysis, By Product Type (Mattresses & Pillows, Medications), By Sleep Disorder (Insomnia, Sleep Apnea), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies), By End-User, By Region - Industry Forecast 2025-2032

Sleep Aids Market size was valued at USD 78.52 Billion in 2023 and is poised to grow from USD 83.19 Billion in 2024 to USD 132.41 Billion by 2032, growing at a CAGR of 5.95% during the forecast period (2025-2032).

Sleep disorders are conditions that disrupt or weaken sleep patterns, giving rise to daytime sleepiness and other sleep aid symptoms. Inadequate sleep can cause problems in college, in addition to issues with work presentations, weight, thinking, mental health, interpersonal relationships, and the progression of heart disease and diabetes. Insomnia, sleep apnea, restless legs syndrome, and narcolepsy are some of the most widely known sleep disorders. Treatment options for sleep disorders include a variety of medicinal drugs medicines such as pitolisant, modafinil, and armodafinil, as well as supplements, therapy, and medications such as gabapentin, suvorexant, eszopiclone, zolpidem, melatonin, zaleplon, ramelteon, and Lemborexant. Some regular exercises and proper balance of light, noise, and temperature can play a vital role in sleep disorder; because exercises have a therapeutic effect on individuals who suffer from sleep disorders. However, the various side effects of sleep aids medicines on human health, as well as a vast number of patient medication expirations, are expected to impede sleep aids market growth during the forecast period.

US Sleep Aids Market is poised to grow at a sustainable CAGR for the next forecast year.